Chromosome 6-mediated suppression of tumorigenicity in malignant melanoma cell lines provides a model system to identify genes associated with the reversion of the tumorigenic phenotype. Using subtractive cDNA selection, we recently identi®ed a series of novel genes which are dierentially expressed in association with chromosome 6-mediated suppression. We now report the molecular characterization of a novel gene termed AIM2 for (Absent In Melanoma), which represents a 1485 bp cDNA. An open reading frame of 1032 base pairs, corresponding to 344 amino acid residues, is predicted. The predicted protein shares a conserved sequence domain of approximately 200 amino acids with known interferon-inducible genes of both human and mouse. We demonstrate that the AIM2 gene encodes a transcript of approximately 2 kb which is expressed in spleen, small intestine, and peripheral blood leukocytes. In addition, we have localized AIM2 to the long arm of human chromosome 1 (band q22) in a highly conserved region which also contains the known interferon-inducible genes IFI16 and MNDA. We have also demonstrated that, like IFI16 and MNDA, AIM2 is induced in HL60 cells by interferon gamma. Our ®ndings support the existence of a family of genes in this region similar to the well-characterized mouse I®200 gene family.
Introduction
The transformation of normal melanocytes to malignant melanoma cells is thought to result from an accumulation of genetic alterations, although the speci®c genes involved remain largely unknown. Cytogenetic studies have con®rmed the presence of recurring chromosomal alterations which pinpoint the locations of growth regulating genes that may be involved in the progression of human malignant melanoma (Trent et al., 1989; Fountain et al., 1990; Thompson et al., 1995; Kraehn et al., 1995) . Chromosome alterations in malignant melanoma most frequently include a variety of nonreciprocal translocations and simple deletions involving chromosome 1 (Trent et al., 1989; Fountain et al., 1990; Thompson et al., 1995) , complete or partial loss of the long arm of chromosome 6 (Trent et al., 1989; Fountain et al., 1990 ) frequent alterations of the short arm of chromosome 9 (Skolnick et al., 1994; Thompson et al., 1995; Kraehn et al., 1995) and 1p11-q22 (Thompson et al., 1995; Kraehn et al., 1995) . Evidence of a putative tumor suppressor gene on chromosome 6 has been suggested by cytogenetic observation (Trent et al., 1989; Fountain et al., 1990) , by high frequency of loss of heterozygosity (LOH) along 6q (Milliken et al., 1991; Walker et al., 1994) and by studies suggesting that either tumorigenicity or metastasis of melanoma cell lines can be suppressed by the introduction (following micro-cell mediated chromosome transfer) of a normal copy of human chromosome 6 (Trent et al., 1990; You et al., 1995; Ray et al., 1996) .
Recently, we reported the use of a PCR-based cDNA subtractive hybridization technique to isolate a series of novel cDNAs which were expressed exclusively in a chromosome-suppressed melanoma cell line (Ray et al., 1996) . This study documents the molecular characterization of one of these genes, termed AIM2 (for Absent In Melanoma, gene #2), which was shown to belong to an established family of interferoninducible genes located on human chromosome 1. AIM2 bears striking sequence homology at both the DNA and protein levels with two previously recognized members of this gene family, IFI16 and MNDA (Trapani et al., 1992; Briggs et al., 1994) , as well as with several members of the murine I®200 cluster of interferon-inducible genes (Choubey et al., 1989) . In this report we discuss the isolation of a full length cDNA for AIM2, containing elements which are highly conserved among known interferon-inducible genes, as well as providing preliminary examination of the expression pattern of this gene in various normal human tissues, melanoma cell lines, and normal melanocytes. We also demonstrate that AIM2 expression is induced by interferon gamma in HL60 cells. Our results suggest that AIM2 is a novel member of a family of closely related interferon-inducible genes, located on human chromosome 1, which is similar to the I®200 gene family in the mouse. approximately 1485 bp of unique sequence which included the entire AIM2 coding region. Figure 1 shows the nucleotide sequence of AIM2 with the deduced amino acid sequence of the longest open reading frame noted below. The molecular weight of the predicted polypeptide is 39 487 Da, and the estimated isoelectric point is 9.76. The sequence contains a tyrosine kinase phosphorylation site at amino acid positions 85 ± 92.
The AIM2 consensus sequence shares strong similarity with known human interferon-inducible genes IFI16 (P=3.9e-50), MNDA (P=3.0e-10), and the mouse I®204 gene (P=1.0e-46). The AIM2 cDNA contains an ORF of 1032 bp corresponding to a putative polypeptide of 344 amino acids. BLASTX aligns the predicted AIM2 amino acid sequence with IFI16 (P=3.9e-50), MNDA (P=1.6e-52), and mouse I®204. (P=4.5e-47). Figure 2 shows the alignment of the AIM2 open reading frame with those of IFI16, MNDA and I®204.
Chromosomal localization
A P1 clone positively identi®ed by PCR using sequence-speci®c AIM2 primers was used as a FISH probe to provide sublocalization of the previously reported somatic cell hybrid mapping to chromosome 1 (Ray et al., 1996) . Figure 3 demonstrates the results of FISH to DAPI-banded normal metaphase chromosomes, allowing sublocalization of AIM2 to 1q22.
Expression of AIM2
As documented in Figure 4a , AIM2 demonstrated dierential expression between the parental tumorigenic UACC-903 melanoma cell line and its suppressed subline UACC-903(+6) (Trent et al., 1990; Ray et al., 1996) . Speci®cally, AIM2 was signi®cantly overexpressed following the introduction of human chromosome 6 and its expression coincided with reversion of the tumorigenic phenotype (Ray et al., 1996) . Because Figure 1 The 1485 bp sequence of the AIM2 cDNA with the amino acid sequence of the predicted coding region indicated below the nucleotide sequence. The stop codon is indicated by an asterisk. Boxed nucleotides indicate a polyadenylation signal. The tyrosine kinase phosphorylation site is underlined of the dierential expression pattern in UACC-903(+6), we examined AIM2 expression in normal melanocyte RNA by slot blot and, failed to recognize detectable levels in normal melanocytes (results not shown).
Preliminary information on the tissue distribution of AIM2 expression was obtained by using the AIM2 cDNA as a probe against a multiple tissue Northern blot (Figure 4b ). The expected 2 kb transcript was detected in total RNA from spleen, small intestine, and peripheral blood leukocytes, and a slightly larger transcript was detected in mRNA from testis. AIM2 mRNA expression was signi®cantly higher in spleen than in other tissues, and re-probing the same blots with b-actin con®rmed this pattern of expression.
Induction of AIM2 in HL60, UACC-903 and UACC-903(+6) cells
To examine the eect of IFN-g on AIM2 mRNA expression; the interferon-inducible cell line HL60 was grown for varying periods of time in the presence of IFN-g (100 U/ml). Cells were harvested and RNA was extracted from independent cultures following 0, 6, 12, 24 or 36 h of IFN-g exposure. Northern blots were prepared for hybridization with the AIM2, IFI16, MNDA, and cDNAs ( Figure 5 ). AIM2 induction was of similar time course and magnitude to that of the related interferon inducible genes IFI16 and MNDA. In contrast to MNDA, induction of AIM2 by DMSO was not observed. 
Discussion
In this study we have presented preliminary characterization of a novel gene related to the interferoninducible IFI16 gene family which is dierentially expressed following the suppression of the tumorigenic phenotype in a malignant melanoma cell line. The nucleotide and predicted amino acid sequences demonstrate homology not only to the human interferon-inducible gene IFI16 (Trapani et al., 1992) but also to MNDA (Briggs et al., 1994) , as well as to members of a family of interferon-inducible genes in mouse (Choubey et al., 1989) . Like IFI16 and MNDA, AIM2 is inducible by IFN-g in HL60 cells. This data, combined with cytogenetic mapping of AIM2 to human chromosome band 1q22, supports the previous suggestion (Briggs et al., 1994 ) that a human gene family, closely related to the mouse I®200 family, exists within a linkage group that is conserved between human band region 1q21 ± 32 and distal mouse chromosome 1 (Seldin et al., 1988a,b Briggs et al., (1994) note that while MNDA and D3 both contain a single copy of the conserved amino acid domain and are similar in patterns of expression and cell type-speci®c regulation, they are up-regulated by dierent forms of interferon (a and g, respectively). The expression pattern of AIM2 in normal human tissues, speci®cally in spleen and peripheral blood leukocytes, is consistent with data suggesting that genes in this family may be involved in the blood cell-speci®c response to interferons (Trapani et al., 1992; Tannenbaum et al., 1993; Briggs et al., 1994; Dawson et al., 1995) . However, this gene is clearly expressed in non-lymphoid tissues, and the most striking novel feature of AIM2 expression is the ®nding of marked up-regulation of this gene in the UACC-903(+6) cell line. This dierential expression was not observed with IFI16, leading us to speculate that these genes are regulated dierently in this model system. The role of AIM2 in suppression of the malignant phenotype is currently indeterminate. However, studies are underway to assess the possibility that AIM2 may play a role in tumorigenic reversion. Finally, further studies appear warranted to provide insight into the biologic function of AIM2 as well as the signi®cance of human interferon-inducible genes in the model system.
Materials and methods

Cell culture
HL60, UACC-903 and UACC-903(+6) cells (Trent et al., 1990) were cultured in RPMI 1640 media with 10% fetal bovine serum, 2 mM L-glutamine, 100 units/ml penicillin G sodium, and 100 mg/ml streptomycin sulfate. UACC-903(+6) harbors a psv2neo tag for selection of the introduced normal chromosome 6, requiring the addition of 600 mg/ml G418. Normal human melanocytes (Clonetics, San Diego, California) were grown in media supplied by the manufacturer. Melanocytes were grown for two weeks before harvesting for isolation of total RNA. For interferon induction studies, HL60 cells were incubated in medium containing gamma-interferon, 100 U/ ml (Amersham, Sydney, Australia) for the times indicated or with dimethylsulfoxide (DMSO), 1.25% (v/v) (Ajax Chemicals, Melbourne, Australia).
Northern analyses
Analysis of AIM2 expression in cultured cells was performed using total RNA isolated either by guanidinium isothiocyanate/CsTFA centrifugation (Kingston et al., 1991) Hybridizations were conducted at 428C overnight in hybridization solution containing 56 Denhardt's, 0.75 M, 0.075 M Na citrate, 1% (w/v) SDS, 5% (w/v) dextran sulphate and 200 mg/ml herring sperm DNA. Blots were washed twice in 26 SSC/ 0.1% SDS at 428C, twice in 0.26 SSC/0.1% SDS at 428C, and twice in 0.16 SSC/0.1% SDS at 688C for 15 min per wash followed by exposure to Kodak K-Omat AR ®lm at 7808C. For IFN-g induction experiments, blots were washed to a strigency of 0.016SSC. Analysis of expression in normal human tissues was performed on commercially prepared blots (Clontech, Palo Alto, CA) using the manufacturer's recommended protocol. A b-actin probe was used as a loading control.
PCR mapping and P1 isolation
Preliminary chromosomal assignment was performed using sequence-speci®c oligonucleotide primers against genomic DNAs from the NIGMS Human/Rodent Somatic Cell Hybrid Mapping Panel #2 (Coriell Institute for Medical Research, Camden, NJ). A P1 phage library was screened by PCR using primers 56B-11F4: 5'-GGG AAG CAG GAG ATG TTT CAT G-3' and 56B-11B3: 5'-GGG GGA CAT TAA CCT TTT GTC AG-3', as described previously (Ray et al., 1996) .
Fluorescent in situ Hybridization (FISH)
A P1 clone positively identi®ed by PCR using sequencespeci®c AIM2 primers was labeled with Spectrum-orange dUTP (Vysis, Napersville, IL) by nick-translation and used as a FISH probe for hybridization to metaphase chromosomes from normal peripheral blood lymphocytes as previously described (Pinkel et al., 1986) . Map positions (cytogenetic band and Flpter measurements) were obtained for each hybridization signal in 20 metaphase chromosomes using Band Map 2.2 (Burde et al., 1996) in NIH Image.
Isolation and cDNA sequencing
The GENETRAPPER cDNA Positive Selection System from Gibco-BRL (Life Technologies, Gaithersburg, MD) was utilized with DNA from a spleen cDNA library. Single-stranded DNA was generated with Gene II protein and Exonuclease III and subsequently hybridized to a biotin-tailed oligonucleotide probe. Target cDNA was captured using streptavidin-coated paramagnetic beads. Single-stranded target DNA was then primed and repaired to make a double-stranded DNA molecule. This repaired DNA was used to transform E. coli by electroporation, and candidate clones were isolated. Using vector primers and cDNA-speci®c oligonucleotide primers (Genosys Biotechnologies, Inc., The Woodlands, TX, and The Midland Certi®ed Reagent Co., Midland, TX), cDNA subclones were sequenced to establish a consensus for the AIM2 coding region. All clones were sequenced from both DNA strands. Sequence analysis, including contig assembly, sequence alignments, and consensus formation, was accomplished using DNA STAR software (version 1.58, DNASTAR Inc., Madison, WI). The AIM2 consensus was compared to previously cloned sequences using BLASTN and BLASTX (Altschul et al., 1990) .
